Yantai Zhenghai Bio-Tech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002NZ1
  • SHE: 300653
CNY
15.42
-0.17 (-1.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
78.74
81.03
88.42
87.88
90.43
96.72
70.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
78.74
81.03
88.42
87.88
90.43
96.72
70.87
Raw Material Cost
17.06
17.02
13.38
14.29
14.88
21.76
12.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.01
0.00
0.00
Selling and Distribution Expenses
31.87
39.50
45.21
41.43
45.82
38.17
45.68
Other Expenses
1.22
0.89
1.80
1.11
1.31
0.90
0.96
Total Expenditure (Excl Depreciation)
61.10
65.40
76.59
66.85
73.80
68.97
67.42
Operating Profit (PBDIT) excl Other Income
17.6
15.600000000000001
11.799999999999999
21
16.599999999999998
27.799999999999997
3.5
Other Income
1.04
0.70
4.75
4.45
1.02
0.23
4.39
Operating Profit (PBDIT)
21.61
19.61
20.51
29.38
22.50
33.66
13.69
Interest
0.00
0.00
0.00
0.00
0.01
0.00
0.00
Exceptional Items
3.04
2.69
0.16
-1.88
3.57
3.26
1.17
Gross Profit (PBDT)
61.68
64.01
75.04
73.59
75.55
74.96
58.70
Depreciation
5.10
5.10
5.73
5.73
5.68
5.68
5.85
Profit Before Tax
19.55
17.20
14.94
21.77
20.38
31.24
9.01
Tax
0.99
2.45
-0.06
0.85
0.84
4.61
-0.57
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18.56
14.75
15.01
20.92
19.54
26.63
9.58
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18.56
14.75
15.01
20.92
19.54
26.63
9.58
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18.56
14.75
15.01
20.92
19.54
26.63
9.58
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
873.05
904.23
889.48
874.47
853.56
915.41
888.78
Earnings per share (EPS)
0.1
0.08
0.08
0.12
0.11
0.15
0.05
Diluted Earnings per share
0.1
0.08
0.08
0.12
0.11
0.15
0.05
Operating Profit Margin (Excl OI)
19.65%
17.05%
11.34%
21.85%
17.47%
28.7%
4.88%
Gross Profit Margin
31.31%
27.53%
23.38%
31.29%
28.81%
38.17%
20.96%
PAT Margin
23.57%
18.2%
16.97%
23.8%
21.61%
27.53%
13.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -2.84% vs -8.37% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 26.53% vs -2.00% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 8.99% vs 19.62% in Mar 2026

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Yantai Zhenghai Bio-Tech Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
78.74
0
78.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
78.74
0
78.74
Raw Material Cost
17.06
0
17.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
31.87
0
31.87
Other Expenses
1.22
0.00
1.22
Total Expenditure (Excl Depreciation)
61.10
0
61.10
Operating Profit (PBDIT) excl Other Income
17.64
0.00
17.64
Other Income
1.04
0
1.04
Operating Profit (PBDIT)
21.61
0
21.61
Interest
0.00
0
0.00
Exceptional Items
3.04
0
3.04
Gross Profit (PBDT)
61.68
0
61.68
Depreciation
5.10
0
5.10
Profit Before Tax
19.55
0
19.55
Tax
0.99
0
0.99
Provisions and contingencies
0
0
0.00
Profit After Tax
18.56
0
18.56
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
18.56
0
18.56
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.56
0
18.56
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
873.05
0
873.05
Earnings per share (EPS)
0.10
0
0.10
Diluted Earnings per share
0.10
0
0.10
Operating Profit Margin (Excl OI)
19.65%
0%
0.00
19.65%
Gross Profit Margin
31.31%
0%
0.00
31.31%
PAT Margin
23.57%
0%
0.00
23.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.87 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -2.84% vs -8.37% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -12.94% vs -16.61% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.86 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 26.53% vs -2.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -4.62% vs -57.33% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.06 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 8.99% vs 19.62% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -4.19% vs -57.00% in Jun 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.65%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading